CLEVE SHIREY: Open Payments
NPI 1326207325 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 6 companies in 2025. Trend: 2023 $124 · 2024 $539 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: ABILIFY MAINTENA, SPRAVATO, AUSTEDO XR, VRAYLAR, TRINTELLIX, CAPLYTA.
Industry payments across AK — which companies pay providers there.
